4 Pharmaceutical Companies Leading the Breast Cancer Fight

Options

http://247wallst.com/healthcare-business/2015/05/0...

4 Pharmaceutical Companies Leading the Breast Cancer Fight

IMO - of the companies mentioned BMS has the most potential and the dedicated research resources. They were in recent news with melanoma and lung cancer drugs which were approved and very promising. I personally am not impressed with Pfizer after submission of our BZA petition. They had immediate approval of DUAVEE which is a conjugated version of BZA with estrogen for osteoporosis in post-menopause women. Of course, this drug cannot be used in breast cancer patients. So they went after the market for the biggest payback. Merck - I feel they are trying to catch up in oncology research. They do have many vaccine approvals but IMO that is not the same as oncology research. Besides I was not impressed with recent news of Merck patent infringement for a BMS lung cancer drug and the BMS made lawsuit against them. I suppose these companies suing each other is common ptractise. I guess I have a soured view of big pharma now.....


Comments

Categories